Position in DHR
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$351,625
+$10,346 QoQ
Shares Held
1,846
+2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,526
of 2,092 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TRUST POINT INC. holds $3,986,426 across 10 Diagnostics & Research names. DHR ranks #5 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,949 | $977,150 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
1,166 | $617,501 | |
| 3 | LH |
Labcorp Holdings Inc.
|
1,280 | $358,400 | |
| 4 | ICLR |
Icon PLC
|
2,028 | $352,283 | |
| 5 | DHR |
Danaher Corp /De/
This page
|
1,846 | $351,625 | |
| 6 | WAT |
Waters Corp /De/
|
923 | $346,161 | |
| 7 | A |
Agilent Technologies, Inc.
|
2,008 | $266,722 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
205 | $261,889 |
All Filings in DHR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $351,625 | 1,846 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $341,279 | 1,800 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $388,248 | 1,696 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $326,137 | 1,645 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $346,090 | 1,752 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $412,870 | 2,014 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $654,676 | 2,852 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $785,684 | 2,826 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $690,834 | 2,765 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $687,229 | 2,752 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $590,842 | 2,554 | Shares | Sole | 2024-01-23 | |
| No filing history on record for this holder in this stock. | ||||||